Skip to content
#data science Dataset Open access

Uptake of Biosimilar Insulin Aspart Following Implementation of a Regional Prescribing Policy Intervention; An Interrupted Time Series Analysis (dataset)

Nov 2026 · Liverpool John Moores University
Biosimilars and Bioanalytical Methods Pharmaceutical Economics and Policy

Abstract

Background: Biosimilar insulin prescribing policy interventions offer the opportunity for healthcare systems to make substantial financial savings through both new initiations and active switching from reference products, without adverse effects on patient outcomes. In September 2024, a large integrated care board in northern England implemented a policy intervention to increase the prescribing of biosimilar insulin aspart. Aims: The aim of this study was to quantitatively evaluate changes in the uptake of biosimilar insulin aspart following the prescribing policy intervention using an interrupted time series analysis and to estimate the associated financial savings. Methods: Prescribing data were extracted from the Bennett Institute for Applied Data Science Open Prescribing Database and imported into Microsoft Excel. Pre-intervention and post-intervention trends in prescribing across nine sublocations within the integrated healthcare system were analysed by device type using segmented regression within a linear mixed-effects model. Serial autocorrelation was accounted for using a first-order autoregressive covariance structure. Financial savings associated with the increased biosimilar usage were then estimated by comparing observed prescribing with a modelled counterfactual scenario. Results: The prescribing policy intervention was associated with a statistically significant increase in the uptake of biosimilar insulin aspart pre-filled pen devices, which reached a market share of 59% after 19 months. No statistically significant post-intervention effects were identified for cartridges or vials. The policy intervention was associated with estimated savings of approximately £350,000 over the study period. Conclusions: Biosimilar insulin prescribing policy interventions can deliver significant changes in prescribing practice as well as meaningful financial savings, but their effectiveness may vary according to device type and factors such as local implementation.

View source

Similar papers

#computer vision Review Sep 2017

Agile Software Development Methods: Review and Analysis

This publication proposes a definition and a classification of agile software development approaches and analyses ten software development methods that can be characterized as being "agile" against the defined criterion.

P. Abrahamsson, O. Salo, Jussi Ronkainen et al. · 727 citations · ⚡54
#computer vision Jun 2008

The impact of agile practices on communication in software development

The study shows that agile practices improve both informal and formal communication, but indicates that, in larger development situations involving multiple external stakeholders, a mismatch of adequate communication mechanisms can sometimes even hinder the communication.

M. Pikkarainen, Jukka Haikara, O. Salo et al. · 401 citations · ⚡48
#machine learning Review Open access Oct 2014

Software development in startup companies: A systematic mapping study

The results indicate that software engineering work practices are chosen opportunistically, adapted and configured to provide value under the constrains imposed by the startup context.

Nicolò Paternoster, Carmine Giardino, M. Unterkalmsteiner et al. · 394 citations · ⚡54

Trajectory Balance: Improved Credit Assignment in GFlowNets

It is proved that any global minimizer of the trajectory balance objective can define a policy that samples exactly from the target distribution, and empirically demonstrate the benefits of the trajectories balance objective for GFlowNet convergence, diversity of generated samples, and robustness to long action sequenc...

Esmeralda S. Whitammer, Moksh Jain, Emmanuel Bengio et al. · 302 citations · ⚡60

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.